Options: Show MedDRA Preferred Terms
| Side effect | Data for drug | Placebo | Labels |
|---|---|---|---|
| 1 | |||
| Albuminuria | x | ||
| Apnoea | x | ||
| Diarrhoea | x | ||
| Rash | x | ||
| Headache | x | ||
| Malabsorption | x | ||
| Meniere's disease | x | ||
| Nausea | x | ||
| Nystagmus | x | ||
| Oliguria | x | ||
| Pain | x | ||
| Paraesthesia | x | ||
| Tinnitus | x | ||
| Vertigo | x | ||
| Vomiting | x | ||
| Neurotoxicity | x | ||
| Ototoxicity | x | ||
| Azotaemia | x | ||
| Paralysis | x | ||
| Nephropathy toxic | x | ||
| Nephrotoxicity | x | ||
| Drug fever | x | ||
| Hearing impaired | x | ||
| Vestibular toxicity | x | ||
Information about indications was extracted from the indications and usage sections of the labels.
standard – alternative
| 100% | ||
| 75% | ||
| 50% | ||
| 10% | ||
| frequent (1% to 100%) | ||
| infrequent (0.1% to 1%) | ||
| rare (<0.1%) | ||
| postmarketing | ||
| 0% | ||
| no frequency information | ||
| not found on label |